The master’s in pharmaceutical sciences degree program consists of 36 credits, including 13 credits of required courses, at least eight credits of electives, a minimum of nine credits of research and six credits of thesis.
Students develop a program of study in consultation with their mentor, which helps ensure students gain expertise in their principal field. Under the supervision of the program advisor, students can tailor their academic program to prepare them for the career path of their choice.
Learn more about the MSPS program, including prerequisites, courses, program outcomes, admissions and more.
The Master of Science degree requires completion of at least 36 credits. These include 13 credits of required courses, at least 8 credits of elective courses, a minimum of 9 credits of research, and 6 credits of thesis. A program of study is developed individually in consultation with the student's mentor and is designed to ensure expertise in the student’s principal field. This will give students the opportunity, under the supervision of the program advisor, to tailor their academic program to prepare them for the career path of their choice.
Program Courses
Core Courses (13 credits) |
|
|
PHS 601 |
Ethics, Regulation and the Pharmaceutical Pipeline |
1 |
PHS 602 (BPS)
OR
PHS 660 (PEP)
|
Drug Discovery and Development
Biopharmaceutical Regulation, Economics and Policy
|
4
3
|
PHS 627,627L, 628 & 628L (BPS)
OR
PHS 662 (PEP)
|
Instrumental Analysis
Economic Evaluation of Health Care Services and Products
|
3
3
|
PHS 620 |
Biostatistics |
3 |
PHS 618 (PEP) |
Research Design, Statistics, and Literature Evaluation |
3 |
PHS 641 |
Seminar (Course must be repeated for a minimum of 2 credits required) |
1 |
Elective Courses (minimum 8 credits) |
|
|
PHS 611 |
Pharmacokinetics |
3 |
PHS 612 |
Advanced Principles of Drug Action |
4 |
PHS 614 |
Biologics |
2 |
PHS 615 |
Pharmacogenomics and Pharmacogenetics |
2 |
CS 621 |
Bioinformatics and Computational Biology I |
3 |
PHS 621 |
Introduction to Pharmaceutical Manufacturing Process |
3 |
PHS 622 |
Formulation and Manufacturing Laboratory |
2 |
PHS 627/627L |
Instrumental Analysis |
2 |
PHS 628/628L |
Instrumental Analysis |
1 |
PHS 651 |
Quality System for Development and Manufacturing Drugs |
3 |
PHS 661 |
Biomedical Market Access, Pricing and Reimbursement |
3 |
PHS 680 |
Career Success: 1st Step 1000 |
2 |
PHS 690 |
Internship in Pharmaceutical Sciences |
3-6 |
PHS 736 |
Pharmacology of Anti-Cancer Agents |
2 |
PHS 741 |
Structural Biology |
3 |
PHS 742 |
Immunology and Microbiology |
3 |
Research (minimum 9 credits of research or 9 credits of research and rotation) |
|
|
PHS 691
OR
|
Research |
1-9 |
PHS 691
PHS 692
|
Research (6 credit required)
Rotation (3 credits required)
|
6
3
|
Thesis or Non-Thesis Option (6 credits)
|
|
|
PHS 696 |
Capstone (Course must be repeated for 6 credits) |
1-6 |
PHS 698 |
Thesis (Course must be repeated for 6 credits) |
1-6 |
MS in Pharmaceutical Sciences Program Learning Outcomes
BPS Emphasis Program Learning Outcomes are as followed:
- Demonstrates foundational knowledge of the pharmaceutical and biomedical sciences, including current research literature, policies and procedures, and methodology in the student research area.
- Understands biomedical or pharmaceutical sciences by exploring and applying new ideas to current research.
- Effectively communicate scientific principles, ideas, and research results with different audiences at an appropriate level.
PEP Emphasis Program Learning Outcomes are as followed:
- Demonstrates foundational knowledge of pharmaceutical economics and policy, including current research literature, policies and procedures, and methodology in the student research area.
- Understands health outcomes and pharmacoeconomic research to address health economic, regulatory, and practice factors that improve population health.
- Effectively communicate scientific principles, methodological rationale, and research results with different audiences at an appropriate level.